Literature DB >> 20068146

ETS-1 oncogenic activity mediated by transforming growth factor alpha.

Chet E Holterman1, Aleksandra Franovic, Josianne Payette, Stephen Lee.   

Abstract

Inappropriate expression of Ets-1 is observed in a variety of human cancers, and its forced expression in cultured cells results in transformation, autonomous proliferation, and tumor formation. The basis by which Ets-1 confers autonomous growth, one of the primary hallmarks of cancer cells and a critical component of persistent proliferation, has yet to be fully explained. Using a variety of cancer cell lines, we show that inhibition of Ets-1 blocks tumor formation and cell proliferation in vivo and autonomous growth in culture. A screen of multiple diffusible growth factors revealed that inhibition of Ets-1 results in the specific downregulation of transforming growth factor alpha (TGFalpha), the proximal promoter region of which contains multiple ETS family DNA binding sites that can be directly bound and regulated by Ets-1. Notably, rescuing TGFalpha expression in Ets-1-silenced cells was sufficient to restore tumor cell proliferation in vivo and autonomous growth in culture. These results reveal a previously unrecognized mechanism by which Ets-1 oncogenic activity can be explained in human cancer through its ability to regulate the important cellular mitogen TGFalpha.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20068146     DOI: 10.1158/0008-5472.CAN-09-2090

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Gene transfer efficiency and genome-wide integration profiling of Sleeping Beauty, Tol2, and piggyBac transposons in human primary T cells.

Authors:  Xin Huang; Hongfeng Guo; Syam Tammana; Yong-Chul Jung; Emil Mellgren; Preetinder Bassi; Qing Cao; Zheng Jin Tu; Yeong C Kim; Stephen C Ekker; Xiaolin Wu; San Ming Wang; Xianzheng Zhou
Journal:  Mol Ther       Date:  2010-07-06       Impact factor: 11.454

2.  Ets1 blocks terminal differentiation of keratinocytes and induces expression of matrix metalloproteases and innate immune mediators.

Authors:  Priyadharsini Nagarajan; Shu Shien Chin; Dan Wang; Song Liu; Satrajit Sinha; Lee Ann Garrett-Sinha
Journal:  J Cell Sci       Date:  2010-10-15       Impact factor: 5.285

3.  Blockade of Ets-1 attenuates epidermal growth factor-dependent collagen loss in human carotid plaque smooth muscle cells.

Authors:  Velidi H Rao; Vikrant Rai; Samantha Stoupa; Devendra K Agrawal
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-08-07       Impact factor: 4.733

4.  ETS1 regulates the expression of ATXN2.

Authors:  Daniel R Scoles; Lance T Pflieger; Khanh K Thai; Stephen T Hansen; Warunee Dansithong; Stefan-M Pulst
Journal:  Hum Mol Genet       Date:  2012-08-21       Impact factor: 6.150

5.  ETS1 mediates MEK1/2-dependent overexpression of cancerous inhibitor of protein phosphatase 2A (CIP2A) in human cancer cells.

Authors:  Anchit Khanna; Juha Okkeri; Turker Bilgen; Timo Tiirikka; Mauno Vihinen; Tapio Visakorpi; Jukka Westermarck
Journal:  PLoS One       Date:  2011-03-22       Impact factor: 3.240

Review 6.  Contributions of epithelial-mesenchymal transition and cancer stem cells to the development of castration resistance of prostate cancer.

Authors:  Ping Li; Ru Yang; Wei-Qiang Gao
Journal:  Mol Cancer       Date:  2014-03-12       Impact factor: 27.401

7.  Transcriptional silencing of ETS-1 abrogates epithelial-mesenchymal transition resulting in reduced motility of pancreatic cancer cells.

Authors:  Chunyan Li; Zhonghan Wang; Yan Chen; Min Zhou; Haijun Zhang; Rong Chen; Fangfang Shi; Cailian Wang; Zongdao Rui
Journal:  Oncol Rep       Date:  2014-11-21       Impact factor: 3.906

8.  PAX3 and ETS1 synergistically activate MET expression in melanoma cells.

Authors:  J D Kubic; E C Little; J W Lui; T Iizuka; D Lang
Journal:  Oncogene       Date:  2014-12-22       Impact factor: 9.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.